Stenocare
39stories
Stenocare · page 4
- CBD Market
2022 Will See The Race To The Bottom Replaced By A Healthy Focus On Profitable Business Models
Stenocare CEO Thomas Skovlund Schnegelsberg reflects on 2021 and looks ahead to the challenges and opportunities that lie ahead in 2022 BC: What are the main opportunities and challenges for the European cannabis industry in 2022?
- Press releases
STENOCARE Comments On The Business Perspective Of Its Danish Indoor Cultivation Facility
Following the completion of the Danish facility upgrade, STENOCARE has shared three video tours from inside the facility.
- News
Danish Cultivator Completes New Facility Gearing Itself For ‘High-Volume Production’
STENOCARE has informed investors that the completion of its pharma-grade cultivation facility is an ‘important milestone’ on its journey towards profitability, despite reporting no sales and increasing losses in its third quarter.
